The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.

New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.

A physician defends her position that children should only participate in clinical trials when they have child assent and the parents also have been educated about the purpose of the research when there is no direct benefit to the child.

Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies.

The American Academy of Pediatrics Task Force on the Family recommends that pediatricians take a more active role in helping to insure that the family environment is conducive to a child's emotional and physical well-being.

Readers are referred to a JAMA article by Ashley Wazana to discuss whether gifts of industry bias physician attitudes and alter prescribing decisions.

Research is needed on surrogates’ susceptibility to believing that clinical trials provide individual therapeutic benefit.

Review of an article that takes the position that the hospital/physician-employee relationship can work if it is built on the socially directed ideals both parties share.

A survey suggests that there is broad consensus among physicians about the importance of honesty with patients, but there is variation in physicians' behavior in disclosing certain information to patients.